Cargando…

Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients

Kaposi’s sarcoma-associated herpes virus (KSHV) is the etiologic agent for Kaposi’s sarcoma (KS). The prognostic utility of KSHV and HIV-1 (human immunodeficiency virus) viremia as well as immunological parameters in clinical management of participants with KS is unclear. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lidenge, Salum J., Tso, For Yue, Mortazavi, Yasaman, Ngowi, John R., Shea, Danielle M., Mwaiselage, Julius, Wood, Charles, West, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352224/ https://www.ncbi.nlm.nih.gov/pubmed/32560243 http://dx.doi.org/10.3390/cancers12061594

Ejemplares similares

Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
por: Lidenge, Salum J., et al.
Publicado: (2020)

RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism
por: Tso, For Yue, et al.
Publicado: (2018)

The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
por: Mortazavi, Yasaman, et al.
Publicado: (2020)

Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020)

Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis
por: Lidenge, Salum J., et al.
Publicado: (2020)

Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome
por: Ngalamika, Owen, et al.
Publicado: (2021)

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa
por: Tso, For Yue, et al.
Publicado: (2021)

SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
por: Ngalamika, Owen, et al.
Publicado: (2023)

Lower SARS-CoV-2 Seroprevalence among Cancer Patients in Sub-Saharan Africa
por: Tso, For Yue, et al.
Publicado: (2022)

SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
por: Ngalamika, Owen, et al.
Publicado: (2022)

Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report
por: Julius, Peter, et al.
Publicado: (2023)

Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states
por: Privatt, Sara R., et al.
Publicado: (2023)

Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence
por: Ngalamika, Owen, et al.
Publicado: (2021)

Unveiling kaposi sarcoma viral antigens
por: Lee, Jaeyeun, et al.
Publicado: (2017)

Elevated iNOS and 3′-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model
por: Vladimirova, Olga, et al.
Publicado: (2023)

Viral Profiling Identifies Multiple Subtypes of Kaposi’s Sarcoma
por: Hosseinipour, Mina C., et al.
Publicado: (2014)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
por: Tso, For Yue, et al.
Publicado: (2021)

Kaposi's sarcoma.
por: Dalgleish, A. G.
Publicado: (1991)

Upregulation of Cell Surface Glycoproteins in Correlation with KSHV LANA in the Kaposi Sarcoma Tumor Microenvironment
por: Privatt, Sara R., et al.
Publicado: (2023)

Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus
por: Minhas, Veenu, et al.
Publicado: (2014)

Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma
por: Dittmer, DP, et al.
Publicado: (2009)

The malignant potential of HIV-associated Kaposi sarcoma
por: Wood, Neil H, et al.
Publicado: (2008)

Primary Kaposi sarcoma of the subcutaneous tissue
por: Pantanowitz, Liron, et al.
Publicado: (2008)

Sarcoma de Kaposi /
por: Jiménez Jiménez, Leticia
Publicado: (1995)

Kaposi's Sarcoma in Nigeria
por: Maclean, Catherine M. U.
Publicado: (1963)

Gastric Kaposi’s sarcoma
por: Teixeira, Veluma Lopes, et al.
Publicado: (2015)

Bronchopulmonary Kaposi's sarcoma
por: Bashar, Nada, et al.
Publicado: (2015)

Kaposi sarcoma of the eyelid
por: Chraibi, Fouad, et al.
Publicado: (2018)

Imaging of Kaposi sarcoma
por: Addula, Dhivya, et al.
Publicado: (2021)

Disseminated Kaposi Sarcoma
por: Goyack, Laura E., et al.
Publicado: (2021)

Epidemiology of Kaposi’s Sarcoma
por: Grabar, Sophie, et al.
Publicado: (2021)

Disseminated Kaposi Sarcoma
por: Ma, Jin-Yuan, et al.
Publicado: (2022)

Endemic Kaposi’s Sarcoma
por: Zeinaty, Perla El, et al.
Publicado: (2023)

Glottic Kaposi's sarcoma
por: Xie, YongXiang, et al.
Publicado: (2023)

Incidence of Kaposi Sarcoma in Sweden is Decreasing
por: BIELIAUSKIENE, Giedre, et al.
Publicado: (2020)

Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
por: Kang, G. H., et al.
Publicado: (1998)

Analytical performance of a low‐cost multiplex polymerase chain reaction human papillomavirus genotyping assay for use in Sub‐Saharan Africa
por: Samwel, Kandali, et al.
Publicado: (2018)

Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition
por: Palich, Romain, et al.
Publicado: (2021)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f40vtk7opls7ja1srllbbp136k